What is the CoVax Vaccine Alliance?
The CoVax Vaccine Alliance is one of three pillars of the Access to COVID-19 Tools (ACT) Accelerator, which was launched in April by the World Health Organization (WHO), the European Commission and France in response to this pandemic. Bringing together governments, global health organisations, manufacturers, scientists, private sector, civil society and philanthropy, with the aim of providing innovative and equitable access to COVID-19 diagnostics, treatments and vaccines. The CoVax pillar is focussed on the latter. It is the only truly global solution to this pandemic because it is the only effort to ensure that people in all corners of the world will get access to COVID-19 vaccines once they are available, regardless of their wealth.
The Global COVID-19 Pledging Conference for CoVax Alliance of 4 May 2020, culminated in the creation of the Access to COVID-19 Tools Accelerator (ACT-A), a global collaboration to accelerate...Read More
CoVax mRNA Wiki CoVax mRNA (messenger RNA), in molecular biology, is a single-stranded molecule of RNA that corresponds to the genetic sequence of a gene, and is read by...Read More
CoVax Dexamethasone Wiki CoVax Dexamethasone is a type of corticosteroid medication. It is used in the treatment of many conditions, including rheumatic problems, a number of skin diseases, severe...Read More
COVID-19 Vaccines Global Access, abbreviated as COVAX, is a global initiative aimed at equitable access to COVID-19 vaccines led by the Global Alliance for Vaccines and Immunization, the World Health Organization, the Coalition for Epidemic Preparedness Innovations, and others. Wikipedia
Founders: World Health Organization, European Commission, Government of France